上海一飛生物科技有限公司公司信息

公司名稱: 上海一飛生物科技有限公司

電話: 021-65675885

電子郵件:customer_service@efebio.com

國籍:中國

產品總數(shù):11974

88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

公司提供產品列表

SR4554	SR4554	167648-73-9
Sulesomab	硫索單抗	167747-19-5
Felvizumab	Felvizumab	167747-20-8
GNE-0946	GNE-0946	1677667-24-1
DJ4	化合物DJ4	1681020-24-5
PG 34	化合物 PG 34	1681056-62-1
Rosmantuzumab	Rosmantuzumab	1684393-04-1
Cynandione A	1,1'-(2',3,6,6'-四羥基-[1,1'-聯(lián)苯]-2,3'-二基)二乙酮	168706-29-4
αvβ1 integrin-IN-1	化合物 T13473	1689540-62-2
Flupyrimin	N-[(E)-1-(6-氯-3-吡啶基)甲基-2(1H)-吡啶亞基]-2,2,2-三氟乙酰胺	1689566-03-7
Obexelimab	奧貝利單抗	1690307-05-1
Lanepitant	拉奈匹坦	170566-84-4
ARTD10/PARP10-IN-1	ARTD10/PARP10抑制劑1	1708103-76-7
1-vinylpyrene	1-乙烯	17088-21-0
Frunevetmab	夫盧維單抗	1708936-80-4
Emapalumab	依瑪魯單抗	1709815-23-5
Sodium zirconium cyclosilicate	環(huán)硅酸鋯鈉	17141-74-1
Igovomab	伊戈伏單抗	171656-50-1
Piprozolin	哌普唑林	17243-64-0
tert-Butyl (6-iodohexyl)carbamate	TERT-BUTYL 6-IODOHEXYLCARBAMATE	172846-36-5
Inophyllum E	紅厚殼（種）內酯	17312-31-1
NDH-1 inhibitor-1	N-(3,4-二甲氧基芐基)-2-萘甲酰胺	173964-49-3
(E)-3-(2-Chloro-4-fluorophenyl)acrylic acid	AA	174603-37-3
Keliximab	凱利昔單抗	174722-30-6
Tidembersat	TIDEMBERSAT	175013-73-7
Tagatose	化合物 T34770	17598-81-1
Roxifiban acetate	化合物 T24733	176022-59-6
CYP1B1-IN-5	CYP1B1抑制劑5	176442-56-1
Izonsteride	IZONSTERIDE	176975-26-1
MMP2-IN-2	5-硝基-2-(4-硝基苯基)-1H-苯并咪唑	1772-39-0
Phenmedipham-d3	甜菜寧-D3	1773497-41-8
ATX-002	ATX-002	1777792-34-3
Sarizotan 2HCl	SARIZOTAN 2鹽酸鹽	177976-12-4
Opaviraline	奧帕韋蘭	178040-94-3
Telisotuzumab	Telisotuzumab	1781223-80-0
BMS-599626 2HCL(714971-09-2 Free base)	化合物 BMS-599626 2HCL(714971-09-2 FREE BASE)	1781932-33-9
RKI-1447 dihydrochloride	RKI 1447 dihydrochloride	1782109-09-4
ML 120B dihydrochloride	MLN120B DIHYDROCHLORIDE	1782573-78-7
Xanthine amine congener hydrochloride	N-(2-氨基乙基)-2-(4-(2,6-二氧代-1,3-二丙基-2,3,6,7-四氫-1H-嘌呤-8-基)苯氧基)乙酰胺鹽酸鹽	1783977-95-6
LDN-209929 dihydrochloride	化合物 LDN-209929 DIHYDROCHLORIDE	1784281-97-5
FK 866 hydrochloride (658084-64-1 free base)	N-[4-(1-Benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-2-propenamide Hydrochloride	1785666-54-7
NLRP3/AIM2-IN-3	化合物 NLRP3/AIM2-IN-3	1787787-60-3
Gosuranemab		1788032-39-2
UC-781	N-[4-chloro-3-(3-methylbut-2-enoxy)phenyl]-2-methyl-furan-3-carbothioamide	178870-32-1
Nav1.7-IN-3	NAV1.7-IN-3	1788872-06-9
WAY-639228	N-(1-芐基哌啶-4-基)萘-2-磺酰胺	179051-05-9
Remtolumab	壬托魯單抗	1791410-27-9
Lutikizumab	Lutikizumab	1791411-57-8
Elezanumab	Elezanumab	1791416-49-3
Dilpacimab	Dilpacimab	1791420-09-1
(2R,5S)-Ritlecitinib	1792180-79-0	1792180-79-0
Vunakizumab	Vunakizumab	1792181-33-9
Porgaviximab	Porgaviximab	1792982-55-8
Crizanlizumab	Crizanlizumab	1690318-25-2
DP00477	化合物 DP00477	169120-56-3
CCT245232	化合物 CCT245232	1693731-14-4
SXC 2023	(R)-2-乙酰氨基-3-((4-甲基苯甲?；?硫基)丙酸	1695562-36-7
Nonabine	諾大麻	16985-03-8
Anisperimus	ANISPERIMUS	170368-04-4
Cevidoplenib	Methanone, cyclopropyl[5-[[4-[4-[[(4S)-4-hydroxy-2-isoxazolidinyl]methyl]-3-methyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-1-methyl-1H-indol-3-yl]-	1703788-21-9
NLRP3-IN-13	NLRP3 抑制劑 13	1704638-35-6
AZ-PFKFB3-67	(2S)-N-[4-[[3-Cyano-1-[(3,5-dimethyl-4-isoxazolyl)methyl]-1H-indol-5-yl]oxy]phenyl]-2-pyrrolidinecarboxamide	1704741-11-6
Lanepitant 2HCl	拉奈匹坦鹽酸鹽	170508-05-1
Larcaviximab	Larcaviximab	1792982-56-9
Cosfroviximab	Cosfroviximab	1792982-57-0
ER-34122	化合物 ER-34122	179325-62-3
Sacituzumab	沙西妥珠單抗	1796566-95-4
Netakimab	Netakimab	1796570-08-5
GNF6702	GNF-6702	1799329-72-8
BCAT-IN-2	BCAT-IN-2	1800024-45-6
Oleoylestrone	雌酮 3-油酸酯	180003-17-2
Vutiglabridin	化合物 VUTIGLABRIDIN	1800188-47-9
Gremubamab	GREMUBAMAB (格瑞巴單抗 )	1800381-36-5
SR12418	化合物 SR12418	1801185-08-9
Odronextamab	奧尼妥單抗	1801338-64-6
Cemiplimab	Cemiplimab	1801342-60-8
RYL-552	化合物 T28636	1801444-56-3
Losatuxizumab	Losatuxizumab	1801544-27-3
Minzasolmin	化合物 MINZASOLMIN	1802518-92-8
ZY-444	化合物 ZY-444	1802650-31-2
RN-1665	化合物 RN-1665	1803003-65-7
Oleclumab	奧來魯單抗	1803176-05-7
GPR40 agonist 6	化合物 GPR40 AGONIST 6	1798751-25-3
PF-04822163	化合物 T28367	1798334-07-2
SB-237376 HCl	Benzamide, N-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]propyl]-4-nitro-, hydrochloride (1:1)	179258-62-9
Basiliximab	巴利昔單抗	179045-86-4
3,4,5-Trihydroxycinnamic acid decyl ester	化合物 3,4,5-TRIHYDROXYCINNAMIC ACID DECYL ESTER	1770778-45-4
YM-58790	化合物YM-58790	168830-70-4
Dyrk1A-IN-5	化合物 DYRK1A-IN-5	1685235-41-9
Propofol-d17 β-D glucuronide	丙泊酚-D17Β-D-葡糖醛酸	1683581-05-6
(R)-VX-11e	(R)-4-(2-((2-氯-4-氟苯基)氨基)-5-甲基嘧啶-4-基)-N-(1-(3-氯苯基)-2-羥基乙基)-1H-吡咯-2-甲酰胺	1680187-43-2
Faralimomab	Faralimomab	167816-91-3
BODIPY FL prazosin	化合物 BODIPY FL PRAZOSIN	175799-93-6
Ravulizumab	Immunoglobulin G2/G4, anti-(human complement C5) (human-Mus musculus ALXN1210 heavy chain), disulfide with human-Mus musculus ALXN1210 κ-chain, dimer	1803171-55-2
RYL-552S	化合物 RYL-552S	1801444-69-8
GSK180	GSK180	1799725-26-0
ABBV-318	ABBV-318	1802848-94-7
Thalidomide-O-amido-CH2-PEG3-CH2-NH-Boc	THALIDOMIDE-O-AMIDO-CH2-PEG3-CH2-NH-BOC	1799711-31-1
SB-237376	化合物 SB-237376	179258-59-4
KL044	9H-Carbazole-9-acetamide, N-(2-chloro-6-cyanophenyl)-	1801856-93-8

88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

上海一飛生物科技有限公司 公司信息

公司提供產品列表

上海一飛生物科技有限公司公司信息